Policy proposals to increase the affordability of anticancer treatments
This project focuses on the affordability of medical treatments. High prices of anticancer drugs are a barrier to patients’ access to effective and appropriate treatments and are stressing healthcare systems. In this project, we are exploring the effects of innovative policies in the intellectual property, pricing, and R&D environment.
This project applies a variety of methods for evidence-based policy making to achieve affordable anticancer treatments. We use a game theory online-experiment to empirically test various levels of transparency on drug prices and R&D investments. Additionally, we use simulation modelling (multi-agent) to quantitatively evaluate and compare the effects of different policies. We also apply qualitative methods, such as scenario-analysis, stakeholder surveys, interviews, and focus groups to engage stakeholders, better understand policies, and build and validate our quantitative models.